Prostate cancer is the most common cancer in men in the UK, with more than 55,000 men being diagnosed every year ...

NHS England has today announced that, for the first time, eligible men with early prostate cancer will be offered pioneering therapy known as SABR on the NHS, which delivers a higher dose to the ...

Audrey is a joyful 6-year-old who loves princesses, playing dress-up, and cuddling with animals. But Audrey’s path to ...

Knowable Magazine reports on a revolutionary CAR T-cell therapy, originally for cancer, now showing promise for autoimmune ...

Dragon Ball is home to countless different transformations, but the greatest forms are on another level design-wise & the ...

Conlon Construction completes first-of-its-kind transformation of Longsight Custody Suite for Greater Manchester Police ...

Northwestern Medicine scientists have discovered that little-studied DNA structures play a central role in organizing the human genome and controlling gene activity, according to a new study published ...

QUEBEC CITY--(BUSINESS WIRE)--Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, ...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest moments—revealing how lung cells with cancer-causing mutations recruit ...

Eli Lilly said it has agreed to acquire biotech company Kelonia Therapeutics. Lilly will pay $3.25 billion upfront and up to $7 billion in total, the company said. Kelonia is developing technology to ...

Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...